Patent ID: 8466200
Filing Date: 2013-06-18
Classification: A61P,C07C,C07D

Abstract:
1. A method for the treatment of a disease or condition selected from the group consisting of metabolic syndrome, diabetes, prediabetes, insulin resistance, low glucose tolerance, hyperglycemia, obesity, dyslipidemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL levels, high LDL levels, glaucoma, osteoporosis, cognitive impairment, anxiety, depression, tuberculosis, leprosy, psoriasis, hypertension, atherosclerosis and its sequelae, vascular restenosis, cardiovascular diseases, pancreatitis, and retinopathy, said method comprising administering to a patient in need thereof an effective amount of a compound of formula I wherein R Z is O or S, R Y is a direct bond or C W is heterocyclyl or heteroaryl, optionally substituted by R R n is 0-2, m is 1-3, R R R R or a pharmaceutically acceptable salt thereof.